Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sodium valproate, platelet dysfunction and bleeding (author's transl)].

P Loiseau

    La Nouvelle Presse Medicale
    |December 19, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of Collisional Effects on Ion-Acoustic Wave Properties in Non-Maxwellian Laser-Driven Plasmas.

    Physical review letters·2025
    Same author

    Experimental Evidence of Stimulated Raman Rescattering in Laser-Plasma Interaction.

    Physical review letters·2025
    Same author

    Statistical model of the stimulated forward Brillouin scattering driven by a randomized laser beam in plasma.

    Physical review. E·2025
    Same author

    Nonlinear kinetic estimate of Raman reflectivity in a hohlraum plasma with a radiation hydrodynamics code.

    Physical review. E·2024
    Same author

    Dynamics of Nanosecond Laser Pulse Propagation and of Associated Instabilities in a Magnetized Underdense Plasma.

    Physical review letters·2023
    Same author

    Influence of a random phase plate on the growth of the backward stimulated Brillouin scatter.

    Physical review. E·2023
    Same journal

    [Forms of intra-erythrocytes asexual multiplication of P. falciparium. Production of monoclonal antibodies].

    La Nouvelle presse medicale·2016
    Same journal

    [Cutaneous systemic angiitis in hairy cell leukemia].

    La Nouvelle presse medicale·1982
    Same journal

    [Isolated late epilepsy as manifestation of glioblastoma. True negative tests with the scanner].

    La Nouvelle presse medicale·1982
    Same journal

    [Non-specific benign ulcer of the colon. Arguments favoring its ischemic origin].

    La Nouvelle presse medicale·1982
    Same journal

    [Relation between psychological stress and obstetrical complications. Preliminary data].

    La Nouvelle presse medicale·1982
    Same journal

    [Significance of a "flat" curve of oral hyperglycemia. Comparison with a test meal].

    La Nouvelle presse medicale·1982
    See all related articles

    Sodium valproate (VPA) can cause thrombocytopenia and platelet dysfunction, particularly at higher doses. Monitoring is advised for patients undergoing surgery or infection, with a daily dose limit of 40 mg/kg.

    Area of Science:

    • Neurology
    • Hematology

    Context:

    • Sodium valproate (VPA) is an antiepileptic drug with known associations with bleeding risks.
    • Thrombocytopenia and platelet dysfunction are potential adverse effects reported in patients on VPA therapy.

    Purpose:

    • To investigate the incidence and clinical significance of VPA-induced thrombocytopenia and platelet dysfunction.
    • To determine the dose-dependency and potential mechanisms of these hematological side effects.

    Summary:

    • Sodium valproate (VPA) is confirmed to cause thrombocytopenia and platelet dysfunction.
    • These side effects are dose-dependent, with a recommended maximum daily dosage of 40 mg/kg.
    • The exact mechanism remains unclear, but effects are considered idiosyncratic and clinically relevant mainly during infection or surgery.

    Related Experiment Videos

    Impact:

    • Highlights the importance of dose management for VPA to mitigate bleeding risks.
    • Suggests the need for coagulation studies in specific clinical scenarios (infection, surgery) for patients on VPA.
    • Informs clinical practice regarding the potential hematological complications of sodium valproate treatment.